Purixan
Purixan is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including PURIXAN. Available dosage form: suspension.
Drug Details
- Generic Name
- Purixan
- Brand Names
- PURIXAN
- Application Number
- NDA205919
- Sponsor
- Nova Laboratories, Ltd
- NDC Codes
- 2
- Dosage Forms
- SUSPENSION
- Routes
- ORAL
- Active Ingredients
- MERCAPTOPURINE
Indications and Usage
1 INDICATIONS AND USAGE PURIXAN is a nucleoside metabolic inhibitor indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.( 1.1 ) 1.1 Acute Lymphoblastic Leukemia PURIXAN is indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.